Compile Data Set for Download or QSAR
Report error Found 605 of ic50 data for polymerid = 4602
TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676661(US20240166643, Example 129)
Affinity DataIC50: 0.00200nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676679(US20240166643, Example 147 | US20240166643, Exampl...)
Affinity DataIC50: 0.00200nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676683(US20240166643, Example 151)
Affinity DataIC50: 0.00200nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676550(US20240166643, Example 1)
Affinity DataIC50: 0.00300nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676551(US20240166643, Example 2)
Affinity DataIC50: 0.00300nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676669(US20240166643, Example 137)
Affinity DataIC50: 0.00300nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676675(US20240166643, Example 143)
Affinity DataIC50: 0.00300nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676677(US20240166643, Example 145)
Affinity DataIC50: 0.00300nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676685(US20240166643, Example 153)
Affinity DataIC50: 0.00300nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676579(US20240166643, Example 33)
Affinity DataIC50: 0.00400nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676594(US20240166643, Example 48)
Affinity DataIC50: 0.00400nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676598(US20240166643, Example 53)
Affinity DataIC50: 0.00400nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676602(US20240166643, Example 57)
Affinity DataIC50: 0.00400nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676646(US20240166643, Example 114)
Affinity DataIC50: 0.00400nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676653(US20240166643, Example 121)
Affinity DataIC50: 0.00400nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676654(US20240166643, Example 122)
Affinity DataIC50: 0.00400nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676673(US20240166643, Example 141)
Affinity DataIC50: 0.00400nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676607(US20240166643, Example 62)
Affinity DataIC50: 0.00500nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676624(US20240166643, Example 83)
Affinity DataIC50: 0.00500nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676639(US20240166643, Example 98)
Affinity DataIC50: 0.00500nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676645(US20240166643, Example 113)
Affinity DataIC50: 0.00500nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676647(US20240166643, Example 115)
Affinity DataIC50: 0.00500nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676658(US20240166643, Example 126)
Affinity DataIC50: 0.00500nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676666(US20240166643, Example 134)
Affinity DataIC50: 0.00500nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676676(US20240166643, Example 144)
Affinity DataIC50: 0.00500nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676679(US20240166643, Example 147 | US20240166643, Exampl...)
Affinity DataIC50: 0.00500nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676681(US20240166643, Example 149)
Affinity DataIC50: 0.00500nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676570(US20240166643, Example 24)
Affinity DataIC50: 0.00600nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676596(US20240166643, Example 51)
Affinity DataIC50: 0.00600nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676626(US20240166643, Example 85)
Affinity DataIC50: 0.00600nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676648(US20240166643, Example 116)
Affinity DataIC50: 0.00600nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676649(US20240166643, Example 117)
Affinity DataIC50: 0.00600nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676552(US20240166643, Example 3)
Affinity DataIC50: 0.00700nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676589(US20240166643, Example 43)
Affinity DataIC50: 0.00700nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676668(US20240166643, Example 136)
Affinity DataIC50: 0.00700nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676558(US20240166643, Example 10)
Affinity DataIC50: 0.00800nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676583(US20240166643, Example 37)
Affinity DataIC50: 0.00800nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676601(US20240166643, Example 56)
Affinity DataIC50: 0.00800nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676655(US20240166643, Example 123)
Affinity DataIC50: 0.00800nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676684(US20240166643, Example 152)
Affinity DataIC50: 0.00800nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676605(US20240166643, Example 60)
Affinity DataIC50: 0.00900nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676652(US20240166643, Example 120)
Affinity DataIC50: 0.00900nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676686(US20240166643, Example 154)
Affinity DataIC50: 0.0100nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676608(US20240166643, Example 63)
Affinity DataIC50: 0.0110nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676592(US20240166643, Example 46)
Affinity DataIC50: 0.0120nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676585(US20240166643, Example 39)
Affinity DataIC50: 0.0140nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676595(US20240166643, Example 49)
Affinity DataIC50: 0.0140nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676604(US20240166643, Example 59)
Affinity DataIC50: 0.0140nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676670(US20240166643, Example 138)
Affinity DataIC50: 0.0150nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGlycylpeptide N-tetradecanoyltransferase 1(Human)
Imperial College Innovations Limited; MyricX Pharma Limited

US Patent
LigandPNGBDBM676566(US20240166643, Example 20)
Affinity DataIC50: 0.0160nMAssay Description:The IC50 values of certain Example Compounds of the invention, and for Comparative Examples 1 and 2, for Human NMT1 (HsNMT1) and Plasmodium vivax (Pv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

Displayed 1 to 50 (of 605 total ) | Next | Last >>
Jump to: